Anzeige
Mehr »
Dienstag, 11.08.2026 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Renaissance Capital

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
22.07.Latin American ticket marketplace Ticketplus lowers deal size by 33% ahead of $17 million US IPO
21.07.SPAC ARC Group Securities Acquisition II lowers units offered by 33%, replaces management and sponsor ahead of $100 million IPO
21.07.SPAC Southern Cross Acquisition I prices $100 million IPO, targeting businesses with revenue visibility
21.07.SPAC B&R Technology Merger prices $325 million IPO, targeting tech with AI tailwinds
21.07.Orbital systems developer Gravitics Holdings files for a $125 million Nasdaq listing
20.07.SPAC TCGX Acquisition files for a $75 million IPO, targeting healthcare in Asia
20.07.Womenswear brand Reformation sets terms for $225 million IPO
20.07.Cardiovascular disease biotech Scribe Therapeutics sets terms for $100 million IPO
20.07.Blackstone-backed sandwich chain Jersey Mike's Subs sets terms for $1.0 billion IPO
18.07.US IPO Weekly Recap: Csquare and Standard Nuclear both underwhelm amid cautious market
17.07.US IPO Week Ahead: Quiet IPO calendar primed for potential launches
17.07.Hypoxia-focused biotech NuvOx Therapeutics files for a $20 million IPO
17.07.Acute and chronic pain relief biotech Latigo Biotherapeutics files for a $100 million IPO
17.07.The 2Q26 IPO Market's Law Firm Leaderboard
17.07.Cancer therapies biotech BlossomHill Therapeutics files for a $100 million IPO
17.07.SPAC AMR Resources Acquisition prices $250 million IPO, targeting critical minerals
16.07.SPAC Phalanx Acquisition I files for a $175 million US IPO, targeting financial services
16.07.Cloud computing service provider QumulusAI completes its Nasdaq direct listing
16.07.Small modular reactor fuel developer Standard Nuclear prices previously downsized IPO at $15
16.07.Data center operator Csquare prices IPO at $21, below the range
16.07.Metabolic disorders biotech Vogenx files for a US IPO
15.07.Michael Klein's SPAC Churchill Capital XIII files for a $300 million IPO
15.07.Israel-based ocular disease biotech Tarsier Pharma ups shares offered by 11% ahead of $50 million US IPO
15.07.Cardiovascular diseases biotech Braveheart Bio files for a $100 million IPO
15.07.Small modular reactor fuel developer Standard Nuclear slashes deal size by 58% ahead of $150 million IPO